Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts Nov 19, 2024
Novel Anti-Inflammatory Flops for HFpEF, HFmrEF Phase II trial does hold a few signals that might warrant another attempt Nov 18, 2024
Gene Therapy Promising for Rare Genetic Cardiomyopathy Phase I results show "big improvement" for what is usually progressive hypertrophy, expert says Nov 18, 2024
AI Can Do Whole Echo Reports, Improve Efficiency AI transformation of the way cardiology uses echo "is absolutely going to happen, expert says Nov 17, 2024
Is DOAC a Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm? Japanese trial supports use but event risk might be low enough to suggest a different strategy Nov 17, 2024
Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathy One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial Nov 17, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approved Recent developments of interest in cardiovascular medicine Nov 12, 2024
Inching Toward a Blood Test for Hypertrophic Cardiomyopathy Researchers try to address challenge of distinguishing HCM from other cardiomyopathies Nov 11, 2024
Tricuspid Valve Replacement Finds Surer Footing With TRISCEND II's 1-Year Report Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats Oct 31, 2024
Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Score Recent developments of interest in cardiovascular medicine Oct 29, 2024
No Kidney Benefit With Finerenone in Heart Failure Patients Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome Oct 28, 2024
Major Win for Preemptive TAVR in Symptomless Aortic Stenosis Larger pool of TAVR candidates suggested by EARLY TAVR trial results Oct 28, 2024
Private Equity's Tighter Grip; ApoB Inhibitors vs Liver? Promising New RDN System Recent developments of interest in cardiovascular medicine Oct 22, 2024
COVID's Outsized Heart Risk; Prehab for Cardiac Surgery; Telerobotic Valve Repair Recent developments of interest in cardiovascular medicine Oct 15, 2024
Safety Data Favor Diuretic Strategy Triggered by Cardiac Monitoring Alerts in HF Effectiveness of this personalized approach now under investigation Oct 11, 2024
Elamipretide for Barth Syndrome Survives FDA Advisory Vote Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndrome Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease Oct 09, 2024
Prime Locations for AEDs; Fluctuating Lp(a); Formalized Telestroke Training? Recent developments of interest in cardiovascular medicine Oct 08, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Space Recent developments of interest in cardiovascular medicine Oct 01, 2024
Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF Cardiac myosin inhibitor linked to improvements in biomarkers in small study Sep 30, 2024
Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM Vast majority of trial participants responded to aficamten Sep 30, 2024
Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure? Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF Sep 29, 2024
Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacy Recent developments of interest in cardiovascular medicine Sep 24, 2024
Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathy Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM Sep 20, 2024
Lp(a) Cutoffs by Sex; LBBA Pacing Approvals; Loneliness Not to Blame for CVD? Recent developments of interest in cardiovascular medicine Sep 17, 2024
Are Regulators the Root of the Problem of Serious Device Recalls? Study lays out common gaps in evidence both before and after approval Sep 16, 2024
Defibrillator Positioning; PFA for PVC Ablation; Harvey Weinstein's Heart Surgery Recent developments of interest in cardiovascular medicine Sep 10, 2024
Oral Anticoagulation and TAVR Together: A Recipe for Trouble Continued OAC failed to meet noninferiority in POPular PAUSE TAVI Sep 03, 2024
TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space Recent developments of interest in cardiovascular medicine Sep 03, 2024
Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEF Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
Stenting, TAVR Make Sense Packaged Together for Some Patients NOTION-3 trial informs care for those with severe AS and stable CAD Sep 01, 2024
Another Trial Sides With MitraClip for Functional Mitral Regurgitation RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates Aug 31, 2024
TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitation Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick. Either choice is "acceptable" based on randomized study Aug 31, 2024
Amyloidosis Drug Improves Outcomes, Survival RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrests Recent developments of interest in cardiovascular medicine Aug 27, 2024
Cardiologist’s Date Rape Verdict; Feds Come Down on DOAC Price; POC Test for HF? Recent developments of interest in cardiovascular medicine Aug 20, 2024
Bleeding Better Controlled When Protamine Is Part of TAVR Wrap-Up Routine ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent Aug 14, 2024
